Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001558370-25-011618
Filing Date
2025-08-15
Accepted
2025-08-15 17:16:28
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 sngx-20250815x424b3.htm 424B3 1440372
2 GRAPHIC sngx-20250815x424b3_a001.jpg GRAPHIC 6856
  Complete submission text file 0001558370-25-011618.txt   1451280
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

EIN.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-276511 | Film No.: 251225645
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)